Sort
48,018 grants matching “immunotherapy”
EFFICACY/SAFETY OF MYCOPHENOLATE MOFETIL IMMUNOTHERAPY IN RHEUMATOID ARTHRITIS
$415,629Massachusetts General Hospital · M01 · FY2000 · RR
COMPUTATIONAL TOOLS FOR THE ANALYSIS OF HIGH-THROUGHPUT IMMUNOGLOBULIN SEQUENCING EXPERIMENTS
$415,624Steven H. Kleinstein · Yale University · R01 · FY2020 · AI
Synthetic Studies Related to Cancer Research/Treatment
$415,618Paul Wender · Stanford University · R01 · FY2019 · CA
Advancing the Coordinating Center for the Canine Cancer Immunotherapy Network
$415,594Nicola J Mason · University Of Pennsylvania · U24 · FY2025 · CA
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer
$415,572Joseph Kissil · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
$415,538Xiang Zhang · Baylor College Of Medicine · R01 · FY2021 · CA
Cancer Center Research Training Program
$415,534Stephen Patrick Hunger · University Of Pennsylvania · T32 · FY2018 · CA
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma
$415,518Haian Fu · Emory University · P01 · FY2024 · CA
An innate immune checkpoint in cancer immunotherapy
$415,512Carla Rothlin · Yale University · R01 · FY2021 · CA
Project 1:Al-driven patho-genomic predictive models for personalized treatment of cervical and anal cancers.
$415,503Anant Madabhushi · University Of Miami School Of Medicine · U54 · FY2025 · CA
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
$415,499Yin Wang · University Of Maryland Baltimore · R01 · FY2020 · CA
Clinical trial development in cancer vaccines
$415,410Samir Khleif · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Human Anti-Macaque CCR5 Mabs for Passive Immunotherapy
$415,374Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2006 · AI
Molecular Genetic Analysis of Mycobacterium tuberculosis
$415,354William Robert Jacobs · Albert Einstein College Of Medicine · R37 · FY2006 · AI
Individualized monitoring of treatment response and resistance in patients with metastatic melanoma
$415,333Muhammed Murtaza · Translational Genomics Research Inst · R01 · FY2020 · CA
Modulating Immunity through Dendritic Cell Phagocytic Receptors
$415,317Nina Bhardwaj · New York University School Of Medicine · R01 · FY2011 · AI
Optical imaging of protease activities in the tumor immune microenvironment
$415,290Euna Yoo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Investigating Amino Acid Depletion in the Tumor Microenvironment as a Metabolic Immune Checkpoint
$415,283Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Enhancing CAR-T cell therapy through theranostic targeted radionuclide therapy
$415,260Yanping Yang · Methodist Hospital Research Institute · R21 · FY2024 · CA
Role of type 2 immune response in pancreatic cancer tumorigenesis
$415,258Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Harnessing B Cells after Stem Cell Transplant to Produce Novel CAR-Ts
$415,257Stefanie Sarantopoulos · Duke University · R21 · FY2025 · CA
Development of a pre-clinical syngeneic pig glioma model for research and translational studies
$415,257Robert C Rostomily · Methodist Hospital Research Institute · R21 · FY2024 · CA
Targeting metabolic stress response to improve CAR-T cell efficacy.
$415,257Irene M. Min · Methodist Hospital Research Institute · R21 · FY2024 · CA
Molecular Genetic Analysis of Mycobacterium tuberculosis
$415,237William Robert Jacobs · Albert Einstein College Of Medicine · R37 · FY2007 · AI
Direct and indirect impacts of HIV and ART among older people in community settin
$415,179Ties Boerma · World Health Organization · R01 · FY2015 · AG